PERFORMANCE MEASUREMENT FOR TREATMENT IMPROVEMENT (PMIT)

丹亚国际公司提议开发和评估改善治疗的绩效衡量(PMTI)，这是一个阿片成瘾治疗的绩效衡量系统，将美沙酮治疗质量保证系统(MTQAS)的绩效衡量与基于医疗组织认可联合委员会(JCAHO)和康复设施认可委员会(CARF)标准的指标相结合，以提高阿片成瘾治疗方案的质量。PMTI将包括一个内置机制，将个别治疗方案的绩效数据转化为这些方案的“行动步骤”，并将被设计为一个基于万维网的测量系统，该系统将为阿片成瘾治疗方案提供一种负担得起的手段，收集结果监测数据，接收实时反馈，并与其他治疗方案和/或标准化分数进行比较，以及改进质量的实用建议。在第一阶段，将与一个由工作人员、顾问和专家小组成员组成的专家小组合作，并与创新社会医疗公司的技术咨询合作，开发PMTI系统。还将对该文书进行可行性审查。在第二阶段，将对该工具进行可靠性和有效性评估，并将开发和评估基于网络的版本。在第三阶段，PMTI将向个人阿片成瘾治疗计划、国家酒精和药物治疗服务部门以及管理护理组织销售。拟议的商业应用个人阿片成瘾治疗方案构成了PMTI系统的主要市场。目前，美国大约有850个阿片成瘾门诊治疗计划。PMTI将是一个负担得起的基于网络的绩效评估系统，治疗方案将能够按患者的成本购买该系统。

Danya International, Inc. proposes to develop and evaluate the Performance Measurement for Treatment Improvement (PMTI), a performance measurement system for opioid addiction treatment which will merge the Methadone Treatment Quality Assurance System (MTQAS) performance measures with indicators based on Joint Commission on the Accreditation of Healthcare Organizations (JCAHO) and Commission on the Accreditation of Rehabilitation Facilities (CARF) standards for quality improvement in opioid addiction treatment programs. PMTI will include a built-in mechanism that will translate performance data of individual treatment programs into "action steps" for those programs and will be designed so that it can be programmed as a World Wide Web-based measurement system which will offer opioid addiction treatment programs an affordable means of collecting outcomes monitoring data, receiving real time feedback and comparisons with other treatment programs and/or standardized scores, along with practical recommendations for quality improvement. During Phase I, the PMTI system will be developed in collaboration with an expert team of staff, consultants and expert panel members, and with technical consultation from Creative Socio-Medics Corporation. A feasibility review of the instrument also will be conducted. During Phase II, the instrument will undergo a reliability and validity assessment, and a web-based version will be developed and evaluated. In Phase III, the PMTI will be marketed to individual opioid addiction treatment programs, State departments of alcohol and drug treatment services, and managed care organizations. PROPOSED COMMERCIAL APPLICATION Individual opioid addiction treatment programs constitute a primary market for the PMTI system. Currently, there are approximately 850 outpatient opioid addiction treatment programs in the United States. The PMTI will be an affordable web-based performance measurement system that treatment programs will be able to purchase on a cost per-patient basis.